The present invention provides
thiazole compounds of Formula I wherein W, Y, R0, R2, R4, R1, R6, R7, X1, X2, X3 and X4 are as defined herein, or a stereoisomer,
tautomer, pharmaceutically acceptable salt,
prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of
platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.